Eliezer Zomer
No más puestos en curso
Perfil
Eliezer Zomer is the founder of Alicon Biological Control, which was founded in 2000.
Dr. Zomer's former jobs include Vice President-Product Development at Glycogenesys, Inc. from 1998 to 2000, EVP-Manufacturing & Product Development at Galectin Therapeutics, Inc. from 2002 to 2010, Vice President-Research & Development at Charm Sciences, Inc. in 1998, and Vice President-Product Development at SafeScience, Inc. in 2000.
Dr. Zomer received a doctorate degree from the University of Massachusetts in 1978 and an undergraduate degree from Tel-Aviv University in 1972.
Antiguos cargos conocidos de Eliezer Zomer.
Empresas | Cargo | Fin |
---|---|---|
Alicon Biological Control | Fundador | 01/07/2002 |
Glycogenesys, Inc.
Glycogenesys, Inc. Miscellaneous Commercial ServicesCommercial Services GlycoGenesys, Inc., a biotechnology company, develops novel pharmaceutical products based on carbohydrate compounds and related technologies. The company's lead drug candidate GCS-100, a treatment for various forms of solid tumors and bloodborne cancers, completed a Phase II (a) clinical trial for pancreatic cancer, and also completed a Phase II (a) clinical trial for colorectal cancer. The company focuses on the development of carbohydrate-based pharmaceutical products and related technologies in connection with oncology. It was founded in 1992 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/07/2000 |
SafeScience, Inc. | Corporate Officer/Principal | 01/07/2000 |
Charm Sciences, Inc.
Charm Sciences, Inc. BiotechnologyHealth Technology Charm Sciences, Inc. provides food safety, water quality and environmental diagnostics equipment. It offers allergens, microbial detection, pesticides, test kits and systems for antibiotics, mycotoxins, and sanitation/hygiene (ATP). The company was founded by Shirley Z. Charm in 1978 and is headquartered in Lawrence, MA. | Director Técnico/Científico/I+D | 01/11/1998 |
GALECTIN THERAPEUTICS INC. | Corporate Officer/Principal | - |
Formación de Eliezer Zomer.
University of Massachusetts | Doctorate Degree |
Tel-Aviv University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
GALECTIN THERAPEUTICS INC. | Health Technology |
Empresas privadas | 4 |
---|---|
Glycogenesys, Inc.
Glycogenesys, Inc. Miscellaneous Commercial ServicesCommercial Services GlycoGenesys, Inc., a biotechnology company, develops novel pharmaceutical products based on carbohydrate compounds and related technologies. The company's lead drug candidate GCS-100, a treatment for various forms of solid tumors and bloodborne cancers, completed a Phase II (a) clinical trial for pancreatic cancer, and also completed a Phase II (a) clinical trial for colorectal cancer. The company focuses on the development of carbohydrate-based pharmaceutical products and related technologies in connection with oncology. It was founded in 1992 and is headquartered in Boston, MA. | Commercial Services |
Charm Sciences, Inc.
Charm Sciences, Inc. BiotechnologyHealth Technology Charm Sciences, Inc. provides food safety, water quality and environmental diagnostics equipment. It offers allergens, microbial detection, pesticides, test kits and systems for antibiotics, mycotoxins, and sanitation/hygiene (ATP). The company was founded by Shirley Z. Charm in 1978 and is headquartered in Lawrence, MA. | Health Technology |
SafeScience, Inc. | |
Alicon Biological Control |
- Bolsa de valores
- Insiders
- Eliezer Zomer